Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
GLP-1 and GIP are the two primary incretins
Support Blood Sugar Control : GLP-1 injections stabilize blood sugar by increasing insulin and lowering glucagon, which also helps reduce cravings
Two available products combine a GLP analog with insulin for once-daily SC injection
When to stay at a dose longer than 4 weeks: You're still losing 1 to 2 pounds per week at the current dose You experienced moderate to severe nausea, vomiting, or diarrhea in the first 2 weeks of the current dose Your provider recommends a slower titration due to age, renal function, or other medications When to increase on schedule: Weight loss has slowed to less than 0.5 pounds per week for 2 consecutive weeks You tolerated the current dose with minimal side effects Your fasting glucose (if diabetic) or HbA1c has plateaued above target When NOT to increase: You're experiencing persistent nausea, vomiting more than twice per week, or signs of dehydration You've had an episode of pancreatitis (current or past) You're planning surgery or a medical procedure in the next 4 weeks (GLP-1 agonists delay gastric emptying, which affects anesthesia risk) The maximum FDA-studied dose is 15 mg weekly
US commercial health plan coverage of semaglutide for obesity, April 2023
US$ 29.12
US$ 29.02
US$ 24.91
US$ 26.40
US$ 21.82
US$ 27.29
US$ 25.20
US$ 23.37
US$ 21.25
US$ 22.70
